CA2075201A1 - Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained - Google Patents

Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained

Info

Publication number
CA2075201A1
CA2075201A1 CA002075201A CA2075201A CA2075201A1 CA 2075201 A1 CA2075201 A1 CA 2075201A1 CA 002075201 A CA002075201 A CA 002075201A CA 2075201 A CA2075201 A CA 2075201A CA 2075201 A1 CA2075201 A1 CA 2075201A1
Authority
CA
Canada
Prior art keywords
compositions
dermatological
hydrogen atom
methyl
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002075201A
Other languages
French (fr)
Other versions
CA2075201C (en
Inventor
Alain Meybeck
Frederic Bonte
Christian Marechal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9393284&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2075201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2075201A1 publication Critical patent/CA2075201A1/en
Application granted granted Critical
Publication of CA2075201C publication Critical patent/CA2075201C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations

Abstract

The present invention relates to the use of an a-tocopherol phosphate, especially in its d1 or d form, or an ester thereof, of the general formula (see formula I) in which: R1 is a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, such as the methyl or ethyl radical. in particular, or an a-tocopheryl radi-cal; and R2 is a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, such as a methyl or ethyl radical in particular, or an oxyethylene chain of the formula (see formula II) in which R3 and R4 independently are a hydrogen atom or a methyl radical and n is an integer greater than or equal to 1, or a salt thereof, for preparing a pharma-ceutical, dermatological or cosmetic composition for the prevention or treatment of allergic manifestations such as skin allergy or bronchial asthma, or inflamma-tory manifestations, or for the prevention or treatment of the harmful effects of free radicals.
CA002075201A 1990-01-31 1991-01-30 Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained Expired - Lifetime CA2075201C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9001143A FR2657526B1 (en) 1990-01-31 1990-01-31 USE OF AN ALPHA-TOCOPHEROL PHOSPHATE, OR ONE OF ITS DERIVATIVES, FOR THE PREPARATION OF COSMETIC, DERMATOLOGICAL, OR PHARMACEUTICAL COMPOSITIONS; COMPOSITIONS THUS OBTAINED.
FR9001143 1990-01-31
PCT/FR1991/000055 WO1991011189A1 (en) 1990-01-31 1991-01-30 USE OF AN α-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED

Publications (2)

Publication Number Publication Date
CA2075201A1 true CA2075201A1 (en) 1991-08-01
CA2075201C CA2075201C (en) 2003-12-02

Family

ID=9393284

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002075201A Expired - Lifetime CA2075201C (en) 1990-01-31 1991-01-30 Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained

Country Status (11)

Country Link
US (3) US5387579A (en)
EP (2) EP0652010B1 (en)
JP (1) JP3186763B2 (en)
AT (1) ATE132370T1 (en)
CA (1) CA2075201C (en)
DE (2) DE69128653T2 (en)
DK (1) DK0513104T3 (en)
ES (2) ES2084808T3 (en)
FR (1) FR2657526B1 (en)
GR (1) GR3019341T3 (en)
WO (1) WO1991011189A1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657526B1 (en) * 1990-01-31 1994-10-28 Lvmh Rech USE OF AN ALPHA-TOCOPHEROL PHOSPHATE, OR ONE OF ITS DERIVATIVES, FOR THE PREPARATION OF COSMETIC, DERMATOLOGICAL, OR PHARMACEUTICAL COMPOSITIONS; COMPOSITIONS THUS OBTAINED.
FR2679904A1 (en) * 1991-08-01 1993-02-05 Lvmh Rech Use of a tocopherol phosphate, or of one of its derivatives, in the preparation of cosmetic or pharmaceutical compositions and compositions thus obtained
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
KR950007045B1 (en) * 1992-04-14 1995-06-30 주식회사태평양 Skin cosmetic material containing polyethoxylate vitamin e.
US5350775A (en) * 1992-07-20 1994-09-27 Showa Denko K.K. Benzopyran derivative, method for producing the same and use thereof
CA2179940A1 (en) * 1995-07-18 1997-01-19 Kazumi Ogata Antiallergic composition comprising a phosphoric diester compound
FR2747044B1 (en) * 1996-04-03 1998-06-26 Coletica USE OF PLANT SEEDS AFTER GERMINATION AS A SOURCE OF SUPEROXIDE DISMUTASE AND COSMETIC, PHARMACEUTICAL OR AGRI-FOOD COMPOSITIONS CONTAINING SUCH A PLANT SUPEROXIDE DISMUTASE, AND EXTRACTION PROCESS
FR2754713B1 (en) * 1996-10-22 1999-01-08 Roc Sa USE OF COMPLEXES FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF SENSITIVE SKIN, PREPARATION METHOD AND HYPOALLERGENIC COMPOSITIONS
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE19713368A1 (en) * 1997-03-29 1998-10-01 Beiersdorf Ag Preparations with active ingredients sensitive to oxidation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
ATE444756T1 (en) * 2000-11-14 2009-10-15 Vital Health Sciences Pty Ltd COMPOSITIONS COMPRISING COMPLEXES OF TOCOPHEROL PHOSPHATE DERIVATIVES
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2002040033A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd Formulation containing phosphate derivatives of electron transfer agents
WO2002043765A2 (en) * 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
AU2002317053B2 (en) * 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
KR20050044655A (en) * 2001-12-03 2005-05-12 노바세아, 인크. Pharmaceutical compositions comprising active vitamin d compounds
CN1604772A (en) * 2001-12-13 2005-04-06 生命健康科学有限公司 Transdermal transport of compounds
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
EP1501474A1 (en) * 2002-05-09 2005-02-02 Showa Denko K.K. Skin whitening external preparation
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
US6645514B1 (en) * 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
AU2003296454A1 (en) * 2002-12-19 2004-07-29 Access Business Group International Llc Increasing skin cell renewal with water-soluble vitamin e
KR20050086954A (en) * 2003-01-17 2005-08-30 바이탈 헬스 사이언시즈 피티와이 리미티드 Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
TWI262798B (en) * 2003-12-31 2006-10-01 Ind Tech Res Inst Liposome and drug deliver system
EP1720551B9 (en) 2004-03-03 2011-09-21 Vital Health Sciences Pty Ltd. Alkaloid formulations
US20090004166A1 (en) * 2004-08-03 2009-01-01 Simon Michael West Carrier For Enternal Administration
JP4523388B2 (en) * 2004-11-19 2010-08-11 日本メナード化粧品株式会社 Collagen synthesis promoter and skin external preparation
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
EP1858508A4 (en) * 2005-03-03 2009-01-07 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
CN101247834B (en) * 2005-06-17 2013-10-30 生命健康科学公司 Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
EP2548581A3 (en) * 2005-06-17 2013-02-20 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
FR2891736B1 (en) * 2005-10-12 2007-11-30 Gattefosse Sas Soc Par Actions EXCIPIENT COMPRISING A WAX DERIVATIVE FOR THE MANUFACTURE OF COSMETIC TOPICAL FORMULATIONS
EP1973547A1 (en) * 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
JP4684906B2 (en) * 2006-02-09 2011-05-18 日本メナード化粧品株式会社 Tight junction formation accelerator
CN101431995B (en) 2006-02-21 2012-02-01 玫琳凯有限公司 stable vitamin C compositions
JP4675801B2 (en) * 2006-03-06 2011-04-27 日本メナード化粧品株式会社 ROR activator
JP4781855B2 (en) * 2006-03-08 2011-09-28 日本メナード化粧品株式会社 Composite powder and makeup cosmetic containing the composite powder
JP4675806B2 (en) * 2006-03-16 2011-04-27 日本メナード化粧品株式会社 Annexin activator
FR2921259B1 (en) * 2007-09-26 2015-02-13 Lvmh Rech COSMETIC USE OF TOCOPHEROL PHOSPHATE AS AN ANTI-AGING SKIN AGENT
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5546809B2 (en) * 2009-07-09 2014-07-09 日本メナード化粧品株式会社 Emulsified cosmetics
ES2643643T3 (en) * 2009-12-23 2017-11-23 Phosphagenics Limited Carrier composition for supply of a biologically active compound
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
US8652511B2 (en) 2010-03-30 2014-02-18 Phosphagenics Limited Transdermal delivery patch
FR2969924B1 (en) 2010-12-30 2013-11-15 Lvmh Rech COMPOSITION COMPRISING A TOCOPHEROL PHOSPHATE
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
BR112015003198A2 (en) * 2012-08-23 2017-10-10 Mylan Laboratories Ltd improved injectable formulation of daptomycin.
FR3015247B1 (en) 2013-12-20 2016-12-23 Lvmh Rech USE OF TOCOPHEROL PHOSPHATE AS A MOISTURIZING AGENT
JP6339376B2 (en) * 2014-02-13 2018-06-06 株式会社ファンケル Cosmetics
JP6882321B2 (en) 2015-12-09 2021-06-02 フォスファージニクス リミテッド Pharmaceutical product
BR112019012946A2 (en) 2016-12-21 2019-11-26 Avecho Biotechnology Ltd process

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144325A (en) * 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning
JPS5944375A (en) * 1982-09-06 1984-03-12 Senjiyu Seiyaku Kk Stable aqueous solution of alpha-tocopherol phosphoric ester
JPS59219295A (en) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk Phosphoric diester, its salt, and their preparation
DE3586859D1 (en) * 1984-03-07 1993-01-07 Roshdy Ismail AGENTS FOR TREATING AND PROTECTING THE SKIN.
RO89761A2 (en) * 1984-03-19 1986-07-30 Institutul Oncologic,Ro MEDICINE FOR INCREASING IMMUNITY WITH CELLULAR SUPPORT AND TREATMENT OF MELINE AND VIRAL DISEASES
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
JPS62265299A (en) * 1985-12-18 1987-11-18 Senjiyu Seiyaku Kk Production of alpha-tocopherol, uridinephosphoric acid diester and halogen-substituted compound thereof or their salt
JPS62145019A (en) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk Anti-inflammatory agent
JPS62205091A (en) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk Novel phosphate diester and its salt, preparation thereof and medicinal preparation containing same
JP2526059B2 (en) * 1987-04-28 1996-08-21 千寿製薬株式会社 Anti-ulcer agent
JP2921792B2 (en) * 1987-10-19 1999-07-19 ザ リポソーム カンパニー，インコーポレイテッド Drug system based on tocopherol
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives
FR2628317B1 (en) * 1988-03-09 1991-11-08 Lvmh Rech COMPOSITION BASED ON HYDRATED LIPID LAMID PHASES OR LIPOSOMES CONTAINING SCUTELLARIA EXTRACT, OR AT LEAST ONE FLAVONOID SUCH AS BAICALINE OR BAICALINE AND COSMETIC OR PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, ANTI-ALLERGIC ANTI-ALLERGIC ACTIVITY THE INCORPORANT
US5100654A (en) * 1989-04-07 1992-03-31 Yale University Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair
US5516788A (en) * 1989-06-22 1996-05-14 University Of Bath Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation
FR2657526B1 (en) * 1990-01-31 1994-10-28 Lvmh Rech USE OF AN ALPHA-TOCOPHEROL PHOSPHATE, OR ONE OF ITS DERIVATIVES, FOR THE PREPARATION OF COSMETIC, DERMATOLOGICAL, OR PHARMACEUTICAL COMPOSITIONS; COMPOSITIONS THUS OBTAINED.
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
FR2679904A1 (en) * 1991-08-01 1993-02-05 Lvmh Rech Use of a tocopherol phosphate, or of one of its derivatives, in the preparation of cosmetic or pharmaceutical compositions and compositions thus obtained
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained

Also Published As

Publication number Publication date
DE69116135D1 (en) 1996-02-15
JPH05505393A (en) 1993-08-12
FR2657526A1 (en) 1991-08-02
ES2084808T3 (en) 1996-05-16
JP3186763B2 (en) 2001-07-11
EP0513104B1 (en) 1996-01-03
ES2114645T3 (en) 1998-06-01
EP0513104A1 (en) 1992-11-19
EP0652010A1 (en) 1995-05-10
GR3019341T3 (en) 1996-06-30
DK0513104T3 (en) 1996-05-20
US5656618A (en) 1997-08-12
US5952001A (en) 1999-09-14
DE69128653D1 (en) 1998-02-12
EP0652010B1 (en) 1998-01-07
ATE132370T1 (en) 1996-01-15
DE69116135T2 (en) 1996-08-29
DE69128653T2 (en) 1998-07-23
CA2075201C (en) 2003-12-02
WO1991011189A1 (en) 1991-08-08
US5387579A (en) 1995-02-07
FR2657526B1 (en) 1994-10-28

Similar Documents

Publication Publication Date Title
CA2075201A1 (en) Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
MY115339A (en) Compositions containing micronized nebivolol
CA2094267A1 (en) Use of fatty alcohol based composition for preparing emulsions, method of preparing emulsions and emulsions so obtained
HUP0002348A2 (en) Cosmetic compositions comprising santalins, santarubins for artificially coloring the skin
IL143978A0 (en) Colchinol derivatives as vascular damaging agents
AU2284099A (en) Poly-aminoacid derivatives and their use in compositions for treating keratinousfibres
RU94046018A (en) 3-arylpyrazole derivatives, process for preparation thereof and fungicidal composition based thereon
MY106067A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors.
IL98757A (en) Piperidine derivatives their preparation and pharmaceutical compositions containing them
TW200501995A (en) Treatment for skin
AU1466295A (en) Amino acid derivatives and their use as phospholipase a2 inhibitors
HUP9803028A2 (en) Cyclic nitrones and pharmaceutical compositions containing them
FI954138A (en) Hydroxymethyl furazanecarboxylic acid derivatives and their use in the treatment of cardiovascular diseases
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
CA2149245A1 (en) Novel Isoxazolines as Antiinflammatory Agents
HUP0202820A2 (en) Compositions containing solubilized antiperspirant active
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
EA200600022A1 (en) APPLICATION OF DERIVATIVE BICYCLO [2.2.1] HEPTANA TO PREPARE NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS
ATE186719T1 (en) DL-DI OD. TRI HYDROXYPHENYLGLYCINAL KYLESTER FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC CONDITIONS
CA2079466A1 (en) Novel benzopyran derivatives and an anti-allergic agent possessing the same as the active ingrediant
DE69315069D1 (en) Phenylsubstituierte cycloalkyl-hydroxyharnstoffderivate als lipoxygenase-hemmer
ATE147755T1 (en) DIPEPTIDE DERIVATIVES AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES CONTAINING THESE AS ACTIVE INGREDIENTS
HUP0202340A2 (en) Pharmaceutical compositions containing condensed heterocyclic compounds as active ingredient and their use
IL112739A0 (en) Ayrlthiobenzonitrile compounds, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry